Just when you thought you had heard it all. . . .

Just when you thought you had heard it all. . . .

Just when you thought capitalism couldn't find anything more to sell. . . .

Just when you thought morality may reign in science. . . . .

articles exposing practices such as patenting genes come out.

According to the attached ACLU article, The US PTO has allowed the patent of genes despite the bioethical ideology that patenting something in nature, such as gravity, is wrong.

Twenty percent of our genes are currently patented (or owned) by corporations.

Among these genes include two genetic markers for breast cancer.

These two genes are patented by one company, giving that company the sole ability to decide who can and can not receive testing to verify future risk of a breast cancer diagnosis.

The company can say when, it can say where, and most importantly, it can set the prices based on its patent.

It is a monopolity of breast cancer genetic testing that only the most terrifying science fiction author could have dreamt up.

And it's true.

Thank goodness there is hope. The ACLU has filed a first-of-its-kind lawsuit citing that patents on genes will halt scientific progress and serve as an obstacle to finding cures.

Let's cross our fingers and pray the right choice is made.

To Show your support, go to www.aclu.org/brcastatement

Apparently somethings do have to be micromanaged by law or we risk having the wrong person "own" the knowledge that could save a life.